Carlos Benítez-Barrera, PhD, who leads the Pediatric Auditory Experience and Brain lab, is interested in the impact of early auditory experiences, language development, and speech perception in kids and brings new technical expertise to help advance the field.
Year
Peggy Modaff selected to serve on Little People of America medical advisory board
Peggy Modaff, MS, CGC, a distinguished clinical genetic counselor in the department of pediatrics and clinic coordinator of the Bone Dysplasia Clinic, was selected to serve on the medical advisory board for the non-profit organization Little People of America (LPA).
New study reveals changes in key pathway in Down syndrome
A new paper published by Anita Bhattacharyya, PhD reveals that the differences in brain structure in individuals with Down syndrome (DS or Trisomy 21) may be due to disrupted signaling pathways that alter brain development to result in the incorrect number or placement of cells in the brain.
PKU patients around Wisconsin are grappling with the formula shortage too
People with metabolic disorders who require formula to ensure adequate nutrition are among those dealing with a months long shortage — the Waisman Center at UW-Madison is seeking to help source alternatives, even as such options can be stressful.
Seth Pollak Research Forward Award
UW-Madison recently announced the second round of recipients for the Research Forward program with Seth Pollak, PhD, a Waisman investigator among them.
New method of assessing LEND’s effectiveness evaluates five-year outcome of trainees
From physicians to speech language pathologists, to social workers and nutritionists, there are a wide range of professionals that help to support the services and supports that help people with IDD to thrive.
The Bone Dysplasia Clinic’s many decades of helping families
The start of the Waisman Center’s Bone Dysplasia Clinic was a case of serendipity. It was 1980 and Richard Pauli, MD, a pediatric geneticist, had just arrived at UW-Madison. Over the course of the year, Pauli settled into his new role at UW Hospital. Then in 1981, he was approached by radiologist Len Langer, MD, with a strange request.
Cancer drug may be treatment option for fragile X syndrome
A newer cancer drug may also be a treatment option for a leading intellectual and developmental disability. Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.
El programa de capacitación posdoctoral en Waisman equipa a una nueva generación de científicos en la investigación de discapacidades intelectuales y del desarrollo
Durante más de 26 años, el Programa de Capacitación Postdoctoral en Investigación de Discapacidades Intelectuales y del Desarrollo del centro ha ayudado a dar forma a las carreras y trayectorias de 53 investigadores postdoctorales a través de capacitación multidisciplinaria en investigación social, epidemiológica, conductual y bioconductual sobre discapacidades intelectuales y del desarrollo (IDD, en inglés).
Postdoctoral program equips a new generation of scientists in IDD research
For more than 26 years, the center’s Postdoctoral Training Program in Intellectual and Developmental Disabilities Research has helped shape the careers and research paths of 53 postdoctoral researchers through multidisciplinary training in social, epidemiological, behavioral and biobehavioral research on intellectual and developmental disabilities (IDD).